From Nasdaq: 2025-04-01 16:30:00

Legendary investor Warren Buffett’s advice to be fearful when others are greedy and vice versa is reflected in the Relative Strength Index (RSI), a technical indicator measuring momentum on a scale of 0 to 100. Beam Therapeutics Inc (BEAM) recently hit an RSI of 28.6, indicating oversold territory, with shares changing hands at $17.5501. This suggests a potential buying opportunity as heavy selling may be nearing exhaustion. BEAM’s 52-week range is $17.5501 to $35.25, with the current price at $17.64.

For more oversold stock options, check out the link provided.



Read more at Nasdaq: Beam Therapeutics Becomes Oversold | Nasdaq